Clinical Trials Logo

Alveolar Bone Loss clinical trials

View clinical trials related to Alveolar Bone Loss.

Filter by:

NCT ID: NCT05595746 Completed - Peri-Implantitis Clinical Trials

Radiological Bone Loss on Different Levels of Dental Implants

Start date: October 5, 2020
Phase: N/A
Study type: Interventional

One of the criteria used for long-term implant success is the evaluation of radiographic bone loss. It is known that the keratinized mucosa over the alveolar crest forms a protective barrier against inflammatory infiltration. In addition, it has been reported that the vertical mucosal thickness on the crest is important in the formation of the biological width around the implant. The aim of this study was to evaluate the effect of vertical mucosal thickness on the alveolar crest on peri-implant marginal bone loss around crestal and subcrestal placed platform-switching implants. In this study, patients will be divided into 2 main groups with vertical mucosal thickness of 2 mm and less and more than 2 mm, and both groups will consist of 2 subgroups as crestally and subcrestally according to the implant level placed. A total of 80 implants will be included, 20 implants in each group. Before starting the surgery, after anesthesia is given, the width of the patient's peri-implant keratinized mucosa and the vertical mucosal thickness over the alveolar crest will be measured. Clinical and radiological measurements will be made in all patients during the prosthetic loading session (T0), at 3rd month (T1), 6th month (T2) and 1 year after loading (T3). With standardized control periapical radiographs to be taken as a result of one-year follow-up, the marginal bone loss amount in the implants will be evaluated using soft-ware.

NCT ID: NCT05592821 Completed - Clinical trials for Dental Implant Failed

Clinical and Radiographic Evaluation of Bone and Tissue Level Single Unit Implants: Two-piece Abutment Concept

Start date: December 7, 2020
Phase:
Study type: Observational [Patient Registry]

Dental implants have become one of the most common treatments used for the rehabilitation of lost teeth. The success rate of dental implant treatment is quite high. One of the criteria used for long-term implant success is the evaluation of radiographic marginal bone loss. Implants are used at the bone and tissue level in implant treatment. In this study, it was planned to use 20 implants of the same brand, with a single implant in the bilateral posterior regions in 10 patients.The study will be designed as split-mouth. The implant will be placed at the bone level with the same protocol in the two edentulous areas and the flap will be closed primarily. After 3 months, the substructure of the two-piece abutment concept system will be placed in a region during the healing head placement stage, and the bone level implant will be converted to the tissue level. A conventional healing cap will be placed in the other area. Periapical radiographs will be taken from the patients who participated in our study, as in all implant patients, during the pre-surgical planning phase and after implant placement. With the control periapical radiographs to be taken as a result of one-year follow-up, the marginal bone loss amount in the implants will be evaluated using soft-ware. Clinical measurements will be taken in all patients at the prosthetic loading session and 1 year after loading.

NCT ID: NCT05496608 Completed - Clinical trials for Periodontal Diseases

Treatment of Intrabony Defects With L-PRF Membrane With or Without Collagen Membranes

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

For patients having periodontal intrabony lesions, three treatment modalities were executed to evaluate the effect of protecting Leukocyte rich -Platelet Rich Fibrin harvests (applied in the bony defects) with resorbable collagen membranes. Clinical Outcomes recorded were the Plaque index (PI), Gingival index (GI), probing depth reduction (PD), Clinical attachment level (CAL), and radiographic defect depth changes. For the biochemical evaluation: levels of PDGF-BB and VEGF obtained from crevicular fluid by Perio-Paper strips were assessed using ELIZA.

NCT ID: NCT05494476 Completed - Alveolar Bone Loss Clinical Trials

Stability of the Marginal Bone Around Subcrestal Implants

Start date: October 23, 2020
Phase: N/A
Study type: Interventional

The extent of marginal bone remodeling around the neck of dental implants has been used for many years as a criterion for defining their long-term success. Apico-coronal position represents a crucial factor in this field. This study aims to establish the optimal insertion depth of a subcrestal implant, with the aim of minimizing the bone resorption.

NCT ID: NCT05381467 Completed - Alveolar Bone Loss Clinical Trials

Evaluation of Immediate Implant Placement In The Esthetic Zone Using the Bone Shielding Concept Versus Dual Zone Therapy

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

Immediate implant placement has proven to be a successful treatment procedure that is preferred by patients because of being less traumatic, more time-efficient. Nowadays, the main goal of a successful immediate implant treatment has ceased to be gaining stability and osseointegration, but achieving long-term dimensional stability has become the optimal challenge. Various soft tissue and hard tissue augmentation techniques have been investigated in order to maintain the ridge dimensions following extraction and immediate implant placement.

NCT ID: NCT05363306 Completed - Clinical trials for Bone Atrophy, Alveolar

Apico-coronal Position of Tissue-level Implants Bone Stability

Start date: January 1, 2021
Phase:
Study type: Observational

early marginal bone loss around dental implants may hamper long term prognosis of implant-prosthetic rehabilitation. this study aimed to study the correlation of pico-coronal position of dental implant (from supracrestal, crystal to undergone level) measuring early marginal bone loss through periapical x-ray at surgical time and subsequent follow-ups.

NCT ID: NCT05360511 Completed - Clinical trials for Periodontal Bone Loss

Erythropoietin Gel as an Adjunct to Xenograft in the Surgical Management of Intrabony Periodontal Defects

Start date: July 1, 2022
Phase: Early Phase 1
Study type: Interventional

The aim of the study is to evaluate the use of erythropoietin gel as an adjunct to xenograft in the surgical management of intrabony periodontal defects.

NCT ID: NCT05290376 Completed - Clinical trials for Vertical Alveolar Bone Loss

Clinical Evaluation of RTX Locator Attachments for Implant-supported Mandibular Complete Overdenture

Start date: January 15, 2020
Phase: N/A
Study type: Interventional

This study was conducted to clinically and radiographically evaluate locator RTx attachments for two implant-supported mandibular overdenture using two loading protocols

NCT ID: NCT05198011 Completed - Alveolar Bone Loss Clinical Trials

Three-Dimensional Printed Customized Titanium Mesh for Mandibular Augmentation

Start date: October 1, 2019
Phase: N/A
Study type: Interventional

Completely or partially edentulous patients suffer from resorption of the alveolar bone, they always seek rehabilitation which becomes challenging. Alveolar ridge augmentation is widely done now to offer these patients functional and esthetic restoration. Many techniques have been proposed to obtain good results of ridge augmentation. Titanium Mesh (TiMe) is widely used, also digital and computer-guided surgery now plays an important role to improve the techniques and results in ridge augmentation procedures.

NCT ID: NCT05188898 Completed - Periodontal Pocket Clinical Trials

Treatment of Intraosseous Periodontal Defects With Hyaluronic Acid

Start date: January 12, 2022
Phase: N/A
Study type: Interventional

The aim of the present investigation will be evaluate the healing of periodontal intraosseous defects following Minimally Invasive Non Surgical Debridement (MINSD) and application of a hyaluronic acid-based gel, compared to MINSD alone. A total of 22 patients will be enrolled, selected by inclusion and exclusion criteria and randomly divided in two groups: hyaluronic acid group (HA) and no-hyaluronic acid group (No-HA).